PLx Pharma Winddown Corp. Sublease Income
PLx Pharma Winddown Corp. reported Sublease Income of $145.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-11.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SubleaseIncome · last filed 2022-03-11
- PLx Pharma Winddown Corp. sublease income for the quarter ending 2021-12-31 was $124.31K, a 105.51% increase year-over-year.
- PLx Pharma Winddown Corp. sublease income for the quarter ending 2021-09-30 was -$41.39K, a 168.43% decline year-over-year.
- PLx Pharma Winddown Corp. sublease income for the quarter ending 2021-06-30 was -$499.00, a 100.82% decline year-over-year.
- PLx Pharma Winddown Corp. sublease income for the quarter ending 2021-03-31 was $62.58K, a 1.33% increase year-over-year.
- PLx Pharma Winddown Corp. sublease income for fiscal 2021 was $145.00K, a 40.38% decline from fiscal 2020.
- PLx Pharma Winddown Corp. sublease income for fiscal 2020 was $243.22K, a 3.90% increase from fiscal 2019.
- PLx Pharma Winddown Corp. sublease income for fiscal 2019 was $234.10K.
| Period end | Sublease Income 3 month | Sublease Income 6 month | Sublease Income 9 month | Sublease Income 12 month |
|---|---|---|---|---|
| 2021-12-31 | $124.31K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $82.92K derived: sum of 2 quarters · filed 2022-03-11 | $82.42K derived: sum of 3 quarters · filed 2022-03-11 | $145.00K 10-K · filed 2022-03-11 |
| 2021-09-30 | -$41.39K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$41.89K derived: sum of 2 quarters · filed 2021-11-12 | $20.69K 10-Q · filed 2021-11-12 | $81.18K derived: sum of 4 quarters · filed 2021-11-12 |
| 2021-06-30 | -$499.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $62.08K 10-Q · filed 2021-08-06 | $122.57K derived: sum of 3 quarters · filed 2021-08-06 | $183.06K derived: sum of 4 quarters · filed 2021-08-06 |
| 2021-03-31 | $62.58K 10-Q · filed 2021-05-14 | $123.07K derived: sum of 2 quarters · filed 2021-05-14 | $183.55K derived: sum of 3 quarters · filed 2021-05-14 | $244.04K derived: sum of 4 quarters · filed 2021-05-14 |
| 2020-12-31 | $60.49K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $120.97K derived: sum of 2 quarters · filed 2021-03-12 | $181.46K derived: sum of 3 quarters · filed 2021-03-12 | $243.22K 10-K · filed 2021-03-12 |
| 2020-09-30 | $60.49K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $120.97K derived: sum of 2 quarters · filed 2020-11-13 | $182.73K 10-Q · filed 2020-11-13 | $241.27K derived: sum of 4 quarters · filed 2020-11-13 |
| 2020-06-30 | $60.49K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $122.25K 10-Q · filed 2020-08-14 | $180.79K derived: sum of 3 quarters · filed 2020-08-14 | $239.31K derived: sum of 4 quarters · filed 2020-08-14 |
| 2020-03-31 | $61.76K 10-Q · filed 2020-05-15 | $120.30K derived: sum of 2 quarters · filed 2020-05-15 | $178.82K derived: sum of 3 quarters · filed 2020-05-15 | $237.35K derived: sum of 4 quarters · filed 2020-05-15 |
| 2019-12-31 | $58.54K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $117.06K derived: sum of 2 quarters · filed 2020-03-13 | $175.59K derived: sum of 3 quarters · filed 2020-03-13 | $234.10K 10-K · filed 2020-03-13 |
| 2019-09-30 | $58.52K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $117.05K derived: sum of 2 quarters · filed 2019-11-08 | $175.56K 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $58.52K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $117.03K 10-Q · filed 2019-08-09 | ||
| 2019-03-31 | $58.51K 10-Q · filed 2019-05-10 |